Appointment of Company Secretary & Compliance Officer
Jubilant Life Sciences Ltd has informed BSE that Mr. Rajiv Shah has been appointed as Company Secretary of the Company with effect from February 16, 2015. He shall also be the Compliance officer of the Company. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Cessation of Company Secretary
Jubilant Life Sciences Ltd has informed BSE that Mr. Lalit Jain has retired from the services of the Company w.e.f. close of working hours of January 31, 2015.Accordingly, Mr. Lalit Jain is ceased to be the Company Secretary of the Company w.e.f. close of working hours of January 31, 2015. Announces Q3 Results, Results Press Release, Investors Presentation & Limited Review Report for Dec 31, 2014
Jubilant Life Sciences Ltd has announced the following results for the quarter ended December 31, 2014:The Un-Audited Standalone results for the Quarter ended December 31, 2014The Company has posted a net (loss) of Rs. (84.80) million for the quarter ended December 31, 2014 as compared to Net Profit of Rs. 1645.20 million for the quarter ended December 31, 2013. Total Income has decreased from Rs. 9574.10 million for the quarter ended... Q3 results on Feb 03, 2015
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 03, 2015, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2014 (Q3).Further, as per the Company's Insider Trading Code, the Trading Window for dealing in the securities of the Company would remain closed for all Directors/Officers/Designated Employees... Shareholding Pattern For December 31, 2014
Jubilant Life Sciences Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014. Jubilant Life Sciences receives ANDA approvals for Valsartan Tablets
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated January 06, 2015 titled "Jubilant Life Sciences receives ANDA approvals for Valsartan Tablets". Appointment of Mr. GP Singh as CEO - Jubilant Pharma
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated January 06, 2015, titled "Appointment of Mr. GP Singh as CEO - Jubilant Pharma". Jubilant Life Sciences receives ANDA approvals for Mycophenolate Mofetil and Rizatriptan
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated January 05, 2015, titled "Jubilant Life Sciences receives ANDA approvals for Mycophenolate Mofetil and Rizatriptan". Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE